Skip to main content
Clinical Trials/DRKS00024391
DRKS00024391RecruitingNot Applicable

Evaluation of training courses and education offers within the framework of the Center for Competence Development in Cancer Self-Help (ZfK KSH)

niversitätsklinikum Freiburg Tumorzentrum / CCC Freiburg Professur für Selbsthilfeforschung0 sites1,300 target enrollmentStarted: February 11, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
1,300

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 Years to one (—)
Sex
All

Inclusion Criteria

  • •state after
  • •Diagnosis of cancer, majority, access to internet/email address

Exclusion Criteria

  • •Participants with insufficient German language skills

Investigators

Sponsor
niversitätsklinikum Freiburg Tumorzentrum / CCC Freiburg Professur für Selbsthilfeforschung

Similar Trials

Completed
Phase 4
hospital waste management education and training program among paramedical staff and attenders for the period of 12 months
CTRI/2016/10/007392Dr Ameena45
Withdrawn
Phase 4
Assessment of an Education and Guidance programme for Eliquis Adherence in Non-Valvular Atrial Fibrillation.stroke prevention in Atrial Fibrillation stroke prevention in cardiac arrhythmia10007521
NL-OMON38431Bristol-Myers Squibb40
Active, not recruiting
Not Applicable
Assessment of an Education and Guidance programme for Eliquis Adherence in Non-Valvular Atrial Fibrillation (AEGEAN)Patients with Non-Valvular Atrial Fibrillation with at least one risk factor for stroke and indicated for oral anticoagulant.MedDRA version: 16.0Level: PTClassification code 10003658Term: Atrial fibrillationSystem Organ Class: 10007541 - Cardiac disorders
EUCTR2013-000055-41-ITBristol-Myers Squibb International Corporation1,112
Active, not recruiting
Phase 1
Assessment of an Education and Guidance programme for Eliquis Adherence in Non-Valvular Atrial Fibrillation (AEGEAN)Patients with Non-Valvular Atrial Fibrillation with at least one risk factor for stroke and indicated for oral anticoagulant.MedDRA version: 16.0Level: PTClassification code 10003658Term: Atrial fibrillationSystem Organ Class: 10007541 - Cardiac disorders
EUCTR2013-000055-41-ESBristol-Myers Squibb International Corporation1,217
Active, not recruiting
Phase 1
Assessment of an Education and Guidance programme for Eliquis Adherence in Non-Valvular Atrial Fibrillation (AEGEAN)Patients with diagnosed non-valvular atrial fibrillation or atrial flutter with at least one risk factor for stroke and indicated for oral anticoagulant.MedDRA version: 17.0 Level: PT Classification code 10003658 Term: Atrial fibrillation System Organ Class: 10007541 - Cardiac disorders
EUCTR2013-000055-41-GBBristol-Myers Squibb International Corporation1,217